upexi inc - UPXI

UPXI

Close Chg Chg %
0.99 -0.01 -1.28%

Closed Market

0.97

-0.01 (1.28%)

Volume: 3.76M

Last Updated:

Apr 2, 2026, 4:00 PM EDT

Company Overview: upexi inc - UPXI

UPXI Key Data

Open

$0.95

Day Range

0.91 - 0.98

52 Week Range

0.54 - 22.53

Market Cap

$67.26M

Shares Outstanding

69.34M

Public Float

56.20M

Beta

-0.59

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$4.78

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

7.18M

 

UPXI Performance

1 Week
 
-2.51%
 
1 Month
 
8.32%
 
3 Months
 
-48.96%
 
1 Year
 
-51.74%
 
5 Years
 
N/A
 

UPXI Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 2
Full Ratings ➔

About upexi inc - UPXI

Upexi, Inc. engages in the development, manufacturing, and distribution of consumer products through direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon. Its brands include LuckyTail, Prax, Cure Mushrooms, Moonwlkr, and Gumi Labs. The company was founded on September 5, 2018 and is headquartered in Tampa, FL.

UPXI At a Glance

Upexi, Inc.
3030 North Rocky Point Drive
Tampa, Florida 33607
Phone 1-701-353-5425 Revenue 15.81M
Industry Pharmaceuticals: Other Net Income -13,684,209.00
Sector Health Technology Employees 59
Fiscal Year-end 06 / 2026
View SEC Filings

UPXI Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 1.492
Price to Book Ratio 1.266
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA 0.126
Enterprise Value to Sales -0.097
Total Debt to Enterprise Value -18.192

UPXI Efficiency

Revenue/Employee 267,988.898
Income Per Employee -231,935.746
Receivables Turnover 6.612
Total Asset Turnover 0.215

UPXI Liquidity

Current Ratio 1.744
Quick Ratio 1.708
Cash Ratio 1.624

UPXI Profitability

Gross Margin 63.943
Operating Margin -81.43
Pretax Margin -86.547
Net Margin -86.547
Return on Assets -18.578
Return on Equity -28.328
Return on Total Capital -11.609
Return on Invested Capital -26.806

UPXI Capital Structure

Total Debt to Total Equity 30.83
Total Debt to Total Capital 23.565
Total Debt to Total Assets 22.436
Long-Term Debt to Equity 1.271
Long-Term Debt to Total Capital 0.972
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Upexi Inc - UPXI

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
44.58M 80.68M 26.00M 15.81M
Sales Growth
+85.04% +80.95% -67.77% -39.19%
Cost of Goods Sold (COGS) incl D&A
22.40M 52.58M 16.85M 5.70M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
3.01M 5.46M 3.68M 757.76K
Depreciation
848.05K 1.25M 1.27M 681.00K
Amortization of Intangibles
2.16M 4.21M 2.41M 76.76K
COGS Growth
+65.60% +134.68% -67.94% -66.18%
Gross Income
22.18M 28.10M 9.15M 10.11M
Gross Income Growth
+109.92% +26.68% -67.45% +10.55%
Gross Profit Margin
+49.75% +34.83% +35.18% +63.94%
2022 2023 2024 2025 5-year trend
SG&A Expense
24.83M 35.65M 22.54M 22.99M
Research & Development
- - - -
-
Other SG&A
24.83M 35.65M 22.54M 22.99M
SGA Growth
+171.71% +43.56% -36.77% +1.96%
Other Operating Expense
- - - -
-
Unusual Expense
(297.70K) 3.95M 8.50M (375.47K)
EBIT after Unusual Expense
(2.35M) (11.50M) (21.89M) (12.50M)
Non Operating Income/Expense
5.50K (2.21M) (585.64K) (10.74K)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
215.30K 4.76M 3.12M 1.17M
Interest Expense Growth
-59.41% +2,111.75% -34.38% -62.44%
Gross Interest Expense
215.30K 4.76M 3.12M 1.17M
Interest Capitalized
- - - -
-
Pretax Income
(2.56M) (18.47M) (25.60M) (13.68M)
Pretax Income Growth
-251.19% -620.30% -38.61% +46.55%
Pretax Margin
-5.75% -22.90% -98.47% -86.55%
Income Tax
- (518.40K) (3.05M) (332.10K)
Income Tax - Current - Domestic
80.77K 349.26K 12.70K 13.56K
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(599.17K) (3.40M) (344.80K) (13.56K)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(2.05M) (15.42M) (25.27M) (13.68M)
Minority Interest Expense
- - 54.82K (559.97K)
-
Net Income
(2.10M) (14.86M) (25.27M) (13.68M)
Net Income Growth
-170.52% -607.44% -70.04% +45.85%
Net Margin Growth
-4.71% -18.42% -97.20% -86.55%
Extraordinaries & Discontinued Operations
- - (2.07M) 1.16M
-
Discontinued Operations
- - (2.07M) 1.16M
-
Net Income After Extraordinaries
(2.10M) (16.93M) (24.11M) (13.68M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(2.10M) (16.93M) (24.11M) (13.68M)
EPS (Basic)
-2.5898 -18.9398 -23.4682 -1.7291
EPS (Basic) Growth
-167.47% -631.32% -23.91% +92.63%
Basic Shares Outstanding
811.23K 893.90K 1.03M 7.91M
EPS (Diluted)
-2.5898 -18.9398 -23.4682 -1.7291
EPS (Diluted) Growth
-167.47% -631.32% -23.91% +92.63%
Diluted Shares Outstanding
811.23K 893.90K 1.03M 7.91M
EBITDA
354.87K (2.09M) (9.72M) (12.12M)
EBITDA Growth
-87.14% -689.93% -364.23% -24.68%
EBITDA Margin
+0.80% -2.59% -37.38% -76.64%

Snapshot

Average Recommendation BUY Average Target Price 5.00
Number of Ratings 2 Current Quarters Estimate -0.085
FY Report Date 06 / 2026 Current Year's Estimate -1.08
Last Quarter’s Earnings -0.095 Median PE on CY Estimate N/A
Year Ago Earnings -1.58 Next Fiscal Year Estimate -0.285
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 2 1 2 2
Mean Estimate -0.09 -0.17 -1.08 -0.29
High Estimates 0.02 -0.17 -0.22 -0.06
Low Estimate -0.19 -0.17 -1.94 -0.51
Coefficient of Variance -174.70 N/A -112.61 -111.65

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 2 2
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Upexi Inc - UPXI

Date Name Shares Transaction Value
Nov 20, 2025 Gene Z. Salkind Director 569,470 Open market or private purchase of non-derivative security Non-derivative transaction at $2.65 per share 1,509,095.50
Nov 20, 2025 Gene Z. Salkind Director 168,750 Open market or private purchase of non-derivative security Non-derivative transaction at $2.81 per share 474,187.50

Upexi Inc in the News